课题基金 / 基金详情

项目摘要

项目成果

David A Tuveson的其他基金

相似基金

相关文献

中文摘要
翻译
领导、规划和评价-项目概要/摘要 冷泉港实验室(CSHL)癌症中心由主任大卫Tuveson(细胞 癌症传播计划(Communication in Cancer Program)Tuveson接替前癌症中心主任布鲁斯斯蒂尔曼, 2016年任癌症中心主任。作为董事,Tuveson负责总体方向,规划, 以及分配癌症中心发展和自由支配资金,以支持他对CSHL的愿景 癌症中心,包括支持癌症研究和共享资源。他由四名副秘书长协助。 导演:Adrian Krainer(基因调控和遗传计划),Nicholas Tonks(细胞 癌症通讯计划),劳埃德Trotman(癌症细胞通讯计划),和丹尼斯 罗伯茨(行政)。Krainer,项目副主任,主要负责监督癌症 中心计划,以确保它们符合癌症中心的战略愿景,并确定 癌症相关成员的赠款。运营副总监Tonks主要负责监督 共享资源,以确保他们保持卓越的服务和科学支持。Trotman,Deputy 教育和多样性主任,监督癌症中心的教育计划,在癌症中心提供建议 招募,并协调癌症中心的教育计划与T32癌症培训补助金。 罗伯茨,行政副主任,协调代表癌症的所有行政服务 协助Tonks管理共享资源。Tuveson已经制定了几个变化, CSHL癌症中心,包括任命新的领导层,重组和重塑癌症品牌 中心计划,招募新成员,建立新的共享资源,推出新的 教育举措,并加强癌症中心和诺斯韦尔健康之间的联盟, 促进转化研究。规划和评估对于确保癌症中心保持其 高度创新的研究和一流的共享资源。在癌症中心高级领导的帮助下, 和癌症中心执行委员会,主任已经制定了一个明确的,但灵活的愿景, 即将到来的赠款周期。内部和外部委员会的建议,包括外部咨询委员会, 由癌症中心领导层用于评估计划,并确保战略举措设计良好 并有效实施。CSHL癌症中心领导层致力于维护和持续 改善癌症中心,以确保其作为基础癌症研究的首要机构的地位。
英文摘要
LEADERSHIP, PLANNING AND EVALUATION – PROJECT SUMMARY/ABSTRACT The Cold Spring Harbor Laboratory (CSHL) Cancer Center is led by Director David Tuveson (Cellular Communication in Cancer Program). Tuveson succeeded former Cancer Center Director Bruce Stillman as the Director of the Cancer Center in 2016. As Director, Tuveson is responsible for the overall direction, planning, and allocation of Cancer Center Developmental and discretionary funds to support his vision for the CSHL Cancer Center, including support of cancer research and the Shared Resources. He is assisted by four Deputy Directors: Adrian Krainer (Gene Regulation and Inheritance Program), Nicholas Tonks (Cellular Communication in Cancer Program), Lloyd Trotman (Cellular Communication in Cancer Program), and Denise Roberts (Administration). Krainer, Deputy Director of Programs, is primarily responsible for oversight of Cancer Center Programs to ensure they align with the strategic vision for the Cancer Center, and for determining the cancer relevance of members’ grants. Tonks, Deputy Director of Operations, is primarily responsible for oversight of the Shared Resources to ensure they maintain exceptional services and scientific support. Trotman, Deputy Director of Education and Diversity, oversees Cancer Center educational initiatives, advises in Cancer Center recruitment, and coordinates Cancer Center educational initiatives with those of the T32 Cancer Training Grant. Roberts, Deputy Director of Administration, coordinates all administrative services on behalf of the Cancer Center and aids Tonks in the management of Shared Resources. Tuveson has instituted several changes to the CSHL Cancer Center, including the appointment of new Leadership, reorganization and rebranding of Cancer Center Programs, recruitment of new members, establishing new Share Resources, launching of new educational initiatives, and strengthening the alliance between the Cancer Center and Northwell Health to promote translational research. Planning and evaluation are critical to ensure the Cancer Center maintains its highly innovative research and first-rate Shared Resources. With the help of Cancer Center Senior Leadership and the Cancer Center Executive Committee, the Director has developed a clear, yet flexible, vision for the coming grant cycle. Advice from both internal and external committees, including the External Advisory Board, is used by the Cancer Center Leadership to evaluate plans and ensure that strategic initiatives are well designed and effectively implemented. The CSHL Cancer Center Leadership are committed to maintaining and continually improving the Cancer Center to ensure its position as a premiere institute for basic cancer research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fibroblast Heterogeneity in Pancreatic Cancer
  • 批准号:
    10675741
  • 项目类别:
  • 资助金额:
    $78.02万
  • 财政年份:
    2021
  • 负责人:
    David A Tuveson
  • 依托单位:
Fibroblast Heterogeneity in Pancreatic Cancer
  • 批准号:
    10299050
  • 项目类别:
  • 资助金额:
    $81.89万
  • 财政年份:
    2021
  • 负责人:
    David A Tuveson
  • 依托单位:
Fibroblast Heterogeneity in Pancreatic Cancer
  • 批准号:
    10467049
  • 项目类别:
  • 资助金额:
    $78.0万
  • 财政年份:
    2021
  • 负责人:
    David A Tuveson
  • 依托单位:
Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response
  • 批准号:
    10056198
  • 项目类别:
  • 资助金额:
    $61.57万
  • 财政年份:
    2016
  • 负责人:
    David A Tuveson
  • 依托单位:
海外基金